Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-24

Clinical Trial Update: Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the precision and sensitivity of Tilmanocept uptake value on Tc-99m Tilmanocept planar imaging in rheumatoid arthritis has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tilmanocept (Tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-08-24